Drug Trial Radar · NCT05246280
Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA
Last checked: Nov 20, 2026Latest source record: Jan 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
169
Actual
Start
Mar 2, 2022
Primary completion
Jul 9, 2024
Study completion Jul 9, 2024
Sponsor
- Lead sponsor
- Navidea BiopharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Feb 18, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will confirm the ability of Tc 99m tilmanocept imaging to predict clinical response in individuals with RA who are beginning anti-TNFα therapy.
Conditions
- Rheumatoid Arthritis
Interventions
TC99m-tilmanoceptDrug
Tilmanocept is a radiotracer that accumulates in macrophages by binding to a mannose binding receptor that resides on the surface.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Specificity of Tilmanocept Uptake Value (TUV)Time frame: Up to 213 days
- Sensitivity of Tilmanocept Uptake Value (TUV)Time frame: Up to 213 days
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Attune Health Research
Beverly Hills, California
University of California, San Francisco
San Francisco, California
Highlands Advanced Rheumatology and Arthritis Center
Avon Park, Florida
Believe Clinical Trials
Coral Springs, Florida
Nouvelle Clinical Research
Cutler Bay, Florida
Vida Clinical Research
Kissimmee, Florida
Life Clinical Trials
Margate, Florida
D&H National Research Centers, Inc
Miami, Florida
Advanced Clinical Research of Orlando
Ocoee, Florida
Physician Research Collaboration
Lincoln, Nebraska
Essential Medical Research
Tulsa, Oklahoma
Altoona Center for Clinical Research
Duncansville, Pennsylvania
Arthritis and Osteoporosis Center of Coastal Bend
Corpus Christi, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.